Modifying the Cancer-Immune Set Point Using Vaccinia Virus Expressing Re-Designed Interleukin-2
Nature Communications - United Kingdom
doi 10.1038/s41467-018-06954-z
Full Text
Open PDFAbstract
Available in full text
Date
November 8, 2018
Authors
Publisher
Springer Science and Business Media LLC